Tag: clinical trials
-
Antibody Treatment Shown to Prevent Migraine
9 June 2016. A clinical trial shows an engineered antibody in one week reduced the number of headaches in people who experienced migraines for an average of 18 years. Results of the study testing the experimental treatment appear in yesterday’s issue of the journal Neurology, published by American Academy of Neurology. Migraine is a neurological syndrome…
-
FDA Clears Insomnia Relief Device
8 June 2016. A device that helps people with insomnia get to sleep without taking drugs received clearance for marketing in the U.S. from the Food and Drug Administration. The device, developed by the company Cerêve in Pittsburgh, Pennsylvania, will require a prescription once it’s on the market in the U.S., expected in the second…
-
Precision Medicine Shown to Boost Cancer Outcomes
7 June 2016. An analysis of results from early-stage clinical trials shows trials using treatments for cancer aimed at specific molecular targets had higher response rates and longer survival times than studies not using these targets. The team from University of California in San Diego, led by postdoctoral researcher Maria Schwaederlé, published its findings in…
-
Blood Test Guides Depression Drug Decisions
7 June 2016. A blood test for two key biomarkers can identify drugs for depression that match an individual’s condition with the disease, thus improving chances of success. A team from the lab of psychological medicine professor Carmine Pariante at Kings College London published its findings yesterday in the International Journal of Neuropsychopharmacology. Pariante’s team,…
-
Engineered T-Cells Get Leukemia Response
(6 June 2016) An early-stage clinical trial testing genetically engineered T-cells from the immune system, shows the treatments are effective against a form of leukemia when combined with chemotherapy drugs. Results of the trial were reported by study leader Jae Hong Park of Memorial Sloan Kettering Cancer Center on 4 June at a meeting of…
-
Trial Shows Feasibility of Wearable Dialysis Device
3 June 2016. An early clinical trial shows a wearable device can provide the same dialysis functions as conventional stationary equipment for people with kidney failure. A team from University of Washington in Seattle and Cedar-Sinai Medical Center in Los Angeles reported results of the trial in yesterday’s issue of the journal JCI Insight. The…
-
Patent Given for Non-Invasive Spinal Stimulation Technology
2 June 2016. A New York neuroscientist who invented a device for stimulating the spinal cord from outside the body to relieve muscle spasticity and paralysis, received a patent for his technology. U.S. Patent and Trademark Office awarded patent number 9,283,391 to physical therapy professor Zaghloul Ahmed at College of Staten Island, a division of…
-
FDA Approves Trial Testing Stem Cells for Brain Injuries
Updated 10 June 2016. Gordie Howe died today at age 88. 18 May 2016. A company developing stem cell therapies says the U.S. Food and Drug Administration approved its application for a clinical trial testing stem cell treatments for traumatic brain injury. The intermediate-stage trial, sponsored by Stemedica Cell Technologies Inc. is part of a research…
-
Neurological Biotech Raises $65M in Venture Funds
10 May 2016. A biotechnology company designing treatments for neurological disorders caused by rigidity in nerve cell synapses, is raising $65 million in its first venture funding round. Aptinyx Inc. in Evanston, Illinois, is a spin-off enterprise that formed when Naurex Inc., another biotech company, was acquired by drug maker Allergan plc in September 2015.…
-
Vaccine Shown to Give 1-Year Malaria Protection
10 May 2016. An early-stage clinical trial with healthy volunteers shows an experimental vaccine can protect against malaria infection for as long as 1 year. Results of the trial, conducted by National Institute of Allergy and Infectious Diseases, or NIAID, part of National Institutes of Health, and University of Maryland Medical Center in Baltimore, appear…